ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

Stryker to Pay Over $1 Billion to Settle Recalled Hip Lawsuits

Blue hip implant X-ray

Medical device maker Stryker Corp. agreed to pay $1.43 billion to settle thousands of hip implant lawsuits filed by patients forced to have revision surgery when their implants failed prematurely.

One of Stryker’s attorneys, Kim Catullo, announced the settlement Monday in the Bergen County courthouse before Superior Court Judge Brian Martinotti. According to the proposed agreement, each plaintiff who underwent revision surgery can expect to receive about $300,000.

The devices in question, the Rejuvenate and ABG II metal-on-metal hip implants, caused about 4,000 patients in 39 states to file lawsuits in New Jersey State court and in federal court before U.S. District Judge David Frank in Minnesota. The device maker issued a worldwide recall of the implants in 2012.

Injured by complications related to hip replacements? Get a Free Case Review

In court filings, plaintiffs claimed the implants released metal particles into the blood and surrounding tissue causing intense pain, swelling and a host of other problems that required revision surgery to replace the implants.

Unlike several other device makers, Stryker made its agreements long before any cases made it to trial. Experts say the company settled cases before any could reach a trial because the company probably wanted to avoid a bigger loss.

“It’s odd that they would not try any cases and then settle so early in the litigation process,” University of Richmond law professor Carl Tobias told Bloomberg. “Sounds like they might have been afraid of facing even bigger liability if they didn’t settle them now.”

Another hip implant maker, Johnson & Johnson, paid billions to settle claims related to its DePuy ASR hip after losing millions of dollars in earlier trial verdicts. J&J still faces thousands of suits for the ASR and another implant, called the Pinnacle.

A number of other device makers also face litigation, including Biomet (M2a Magnum), Wright Medical (Conserve) and Zimmer (Durom Cup).

Terms of Rejuvenate/ABG II Settlement

Hip recipients who underwent revision surgery prior to Nov. 3, 2014, are covered in the Rejuvenate/ABG II settlement. All claimants who filed a claim as well as those who have not yet filed are eligible to participate. Stryker is urging patients to contact their attorneys.

While each award is estimated at about $300,000, people who had more than one revision surgery and suffered more severe injuries could be awarded additional money. Serious complications — such as heart attack, foot drop, stroke and death — also may increase the award by as much as $600,000, according to the New Jersey Law Journal.

Also eligible for the settlement are patients who need a revision but cannot have one because it is too risky. Older plaintiffs and any former plaintiff who is now deceased are subject to as much as a 30 percent reduction in award, lowering it to about $210,000.

“The settlement represents one of the largest medical device settlements with an unlimited compensation fund,” Minneapolis lawyer Charles Zimmerman told The Associated Press. Zimmerman helped negotiate the deal as part of the lead-counsel committee for the case. “We are pleased that we were able to reach a settlement with such meaningful relief.”

Plaintiffs’ lawyers worked to speed up the settlement agreement because many of the claimants are elderly.

J&J Paid Billions for DePuy Hip Settlement

Stryker’s move to settle early in the litigation process might keep the company from the same fate as J&J. The New Jersey-based company agreed to settle thousands of its DePuy ASR claims for about $2.5 billion. In addition, the company has to pay for the costs of recalling 93,000 devices and reimburse insurance companies that paid to have the devices removed.

Just last week, Bloomberg reported that J&J may pay an additional $250 million to resolve an additional 1,000 claims.

Styker’s settlement begins on a smaller scale, but as word gets out, more plaintiffs could join.

“We estimate that it will cover about 3,000 patients whose devices have already failed,” plaintiff’s attorney Ellen Relkin told Bloomberg.

Stryker marketed the hips as durable, lasting for several years, but some failed after two. The company is not sure how many people are actually included in the settlement but expects to make the majority of the payments by the end of 2015, reports.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for nearly a decade. She focuses on various medical conditions, health policy, COVID-19, LGBTQ health, mental health and women’s health issues. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • Member of American Medical Writers Association (AMWA) and former Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine

4 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. Voraceacos, D. & Feeley, J. (2014, November 4). Stryker to pay more than $1 billion for recalled devices. Bloomberg. Retrieved from
  2. Jones, A. (2014, November 3). Stryker Corp. to pay at least $1.4 billion to settle hip replacement lawsuits. MLive. Retrieved from
  3. Associated Press. (2014, November 3). Stryker to pay $1.43B to settle hip implant cases. Retrieved from
  4. Gallagher, M-P. (2014, November 3). $1B settlement reached in Stryker hip implant mass tort. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(877) 280-3908